BioSpace News Archive

Eurofins - Transplant Genomics (“TGI”), a molecular diagnostics company committed to improving organ transplant outcomes with non-invasive serial monitoring guided by genomics, today announced patient enrollment will begin in their TRULO (“TruGraf Long-term clinical Outcomes”) registry study.

Restorative Therapies, Inc., announces continued support for healthcare workers and patients by providing products and services across the full continuum of care, from critical care to inpatient and outpatient therapy to in-home care.

Top hospital adopting InsightRTTM platform for innovative approach to integrating historical clinical insights into patient-specific decision making

Aligos Therapeutics, Inc., a preclinical stage biotechnology company focused on the development of targeted therapies for hepatologic diseases and viral infections, including chronic hepatitis B (CHB), nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC), announces the expansion of an existing license agreement with Luxna Biotech Inc., Ltd. pursuant to Luxna’s innovative modified nucleic acid technology.

Medivir AB announces that Linda Basse, Chief Medical Officer at Medivir will leave the company on September 30, 2020.

Pylum Biosciences, Inc., a biotechnology company developing a new class of precision antibacterial medicines, in collaboration with researchers at the University of California, Los Angeles and The University of Texas Medical Branch, today announced the publication of key structural mechanisms of action for a class of naturally occurring bacteria killers, R-type pyocins.

Board Certified Periodontists Dr. Alexandre-Amir Aalam and Dr. Alina Krivitsky of the CENTER For Advanced Periodontal and Implant Therapy in Brentwood, Los Angeles, are the founding periodontists behind the RejuvaGum Lift™, a revolutionary procedure that uses Platelet Rich Fibrin to treat gum recession.

Babson Diagnostics (Babson), a transformative diagnostic blood testing company, announced today it will launch a COVID-19 serology testing service. COVID-19 serology testing is used to detect the presence of antibodies to SARS-CoV-2 in the bloodstream, which makes it the preferred method for evaluating whether a person has had a SARS-CoV-2 infection in the past and whether they may have developed immunity to SARS-CoV-2

Health Canada is temporarily authorizing the use of technical-grade ethanol for use in hand sanitizer products. Health Canada is advising Canadians to always follow the label directions when using alcohol-based hand sanitizers.

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”), a technology development company committed to the fostering of innovative ideas, announced today the closing of its previously announced registered direct offering with several institutional and accredited investors of 14,000,000 shares of its common stock at a purchase price